GeoPolitics Pulse

The Heartbeat of World events

Rhythm Pharmaceuticals Announces European Commission Expands IMCIVREE … – Morningstar

by ·

BOSTON, July 31, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused …Read More

Related posts:

  1. Rhythm Pharmaceuticals Announces IMCIVREE® – GlobeNewswire
  2. Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC
  3. Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC
  4. ARS Pharmaceuticals Announces Filings for Approval of neffy® in China, Japan and Australia
  5. Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic …